This is a competing renewal application of a MERIT award currently in its 36th year of funding. The long-term objectives of these studies have been to elucidate the mechanisms by which systemic hormones and local growth factors regulate the normal development of the mammary gland, and to determine how these regulatory mechanisms have deviated in breast cancer. More than a decade ago our laboratory and others presented evidence that steroid hormone-induced proliferation of mammary ductal epithelial cells was regulated by paracrine mechanisms. Recent studies have indicated that steroid hormone regulation of mammary stem and progenitor cells in both the normal mammary gland and luminal breast cancers is also mediated by local paracrine mechanisms involving Wnts, fibroblast growth factors and Rank ligand. Our current studies combine gain- and loss-of function mouse genetic experiments using transgenic, conditional knockout, and lentivirally-transduced mammary epithelial cells and transplantation into the cleared mammary fat pad with the in situ analysis of signal transduction pathways. They will continue to focus on the understanding of both paracrine, juxtacrine and autocrine mechanisms of cell fate determination in the murine mammary gland with emphasis on the mechanisms regulating stem/progenitor cell self-renewal, normal ductal morphogenesis, and early progression in breast cancer. To accomplish these goals we propose: 1. To elucidate the role of the canonical and non-canonical Wnt pathways in mammary stem/progenitor cell self-renewal and survival. 2. To elucidate the molecular mechanisms of FGFR 1 and FGFR2 action on mammary stem and progenitor cells. 3. To understand the mechanisms of Wnt and Fgf pathway cooperativity in mammary stem/progenitor self- renewal and how these are altered in breast cancer. 4. To delineate the role of specific C/EBPss protein isoforms in both stem cell self-renewal and luminal/alveolar cell fate determination 5. To elucidate the role of noncoding RNAs(ncRNAs) in mammary gland development and breast cancer. "Our understanding of the biology and developmental genetics of the normal mammary gland is a barrier to progress...a more complete understanding of the normal mammary gland at each stage of development....will be a critical underpinning of continued advances in detecting, preventing and treating breast cancer"

Public Health Relevance

Approximately 1 in 8 women will be stricken by breast cancer in their lifetime. Discovering the mechanisms by which hormones regulate normal mammary stem and progenitor cells will be critical to our understanding of the alterations which occur both during both the initiation of breast cancer, as well as during cancer metastasis and disease recurrence.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA016303-38
Application #
8515938
Study Section
Molecular and Cellular Endocrinology Study Section (MCE)
Program Officer
Sathyamoorthy, Neeraja
Project Start
1978-08-01
Project End
2017-05-31
Budget Start
2013-06-01
Budget End
2014-05-31
Support Year
38
Fiscal Year
2013
Total Cost
$709,148
Indirect Cost
$256,018
Name
Baylor College of Medicine
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
051113330
City
Houston
State
TX
Country
United States
Zip Code
77030
Rosen, Jeffrey M; Roarty, Kevin (2014) Paracrine signaling in mammary gland development: what can we learn about intratumoral heterogeneity? Breast Cancer Res 16:202
Shore, Amy N; Rosen, Jeffrey M (2014) Regulation of mammary epithelial cell homeostasis by lncRNAs. Int J Biochem Cell Biol 54:318-30
Pond, Adam C; Bin, Xue; Batts, Torey et al. (2013) Fibroblast growth factor receptor signaling is essential for normal mammary gland development and stem cell function. Stem Cells 31:178-89
Machado, Heather L; Kittrell, Frances S; Edwards, David et al. (2013) Separation by cell size enriches for mammary stem cell repopulation activity. Stem Cells Transl Med 2:199-203
Buser, Adam C; Obr, Alison E; Kabotyanski, Elena B et al. (2011) Progesterone receptor directly inhibits ýý-casein gene transcription in mammary epithelial cells through promoting promoter and enhancer repressive chromatin modifications. Mol Endocrinol 25:955-68
Zhang, Mei; Atkinson, Rachel L; Rosen, Jeffrey M (2010) Selective targeting of radiation-resistant tumor-initiating cells. Proc Natl Acad Sci U S A 107:3522-7
Greene, Stephanie B; Herschkowitz, Jason I; Rosen, Jeffrey M (2010) The ups and downs of miR-205: identifying the roles of miR-205 in mammary gland development and breast cancer. RNA Biol 7:300-4
Boles, Nathan C; Peddibhotla, Sirisha; Chen, Alice J et al. (2010) Chk1 haploinsufficiency results in anemia and defective erythropoiesis. PLoS One 5:e8581
Reddy, Jay P; Peddibhotla, Sirisha; Bu, Wen et al. (2010) Defining the ATM-mediated barrier to tumorigenesis in somatic mammary cells following ErbB2 activation. Proc Natl Acad Sci U S A 107:3728-33
Kabotyanski, Elena B; Rijnkels, Monique; Freeman-Zadrowski, Courtneay et al. (2009) Lactogenic hormonal induction of long distance interactions between beta-casein gene regulatory elements. J Biol Chem 284:22815-24

Showing the most recent 10 out of 80 publications